CAS: 31690-09-2; (S)-2-(4-((((S)-2-Amino-5-Methyl-4-Oxo-3,4,5,6,7,8-Hexahydropteridin-6-yl)Methyl)Amino)Benzamido)Pentanedioic Acid

该化合物是叶酸的一种生物活性形式,一种B-vitamin(B9),在各种生理过程中起着关键作用,对DNA合成,修理和甲基化以及红细胞生产至关重要.L-Mebyfolate在同心血管健康相联系的氨基酸同父体新陈代谢中尤其重要.这种化合物是水溶性,一般是白到苍白的黄色晶体粉.在正常条件下是稳定的,但可以对光和热十分敏感.L-Megyfolate由于与叶酸等其他形式的叶酸相比,其生物利用率有所提高,常常用于补充和强化.这对某些遗传多形态影响将叶酸转化为其活性形态的个人特别有益.此外,L-Mebyfolate已经研究过其在情绪紊乱和其他健康条件下的潜在治疗作用,突出其在营养和医学两方面的重要性.

结构式图片

上下游产品

CAS号59-30-3 叶酸

合成工艺路线路线简述

  • 合成目标产物 Levomefolic Acid 主要起始原料 Folic Acid
  • (文献来源)合成步骤主要原料 Folic Acid
Folate置于sodium Tetrahydroborate,Chloro(1,5-Cyclooctadiene)Rhodium(I) Dimer,水,氢气,三氟乙酸,1,2-Bis[(2S,3S,4S,5S)-3,4-Dihydroxyl-2,5-Dimethylphospholanyl]Benzene体系中,用 Aq. Phosphate Buffer,乙醇 作为反应溶剂,20.0~80.0 °C,3.0 Mpa 条件下,反应 36.0H,反应生成 L-5-甲基四氢叶酸
参考文献:L-5-甲基四氢叶酸钙的制备工艺
标题:L-5-甲基四氢叶酸钙的制备工艺
摘要:本发明涉及一种l‑5‑甲基四氢叶酸钙的制备工艺,采用不对称催化加氢将将叶酸还原为(6S)‑四氢叶酸,叶酸的转化率高,(6S)‑四氢叶酸非对映体过量程度高;通过成盐并结晶,可以容易地富集得到具有极高非对映体过量的(6S)‑四氢叶酸中间体,由此最终制得的l‑5‑甲基四氢叶酸钙的收率和纯度高.本发明的催化加氢工艺在工业应用上十分成熟,操作方便;后续的甲基化和成盐步骤易于实施,在提高了产物收率和纯度的情况下,所述制备工艺具有很高的经济价值和实用价值.

海关参考信息

专利信息


专利号:US-9090925-B2
优先权日:2006-01-20
标 题:Synthesis of (6S)-5,6,7,8-tetrahydrofolic acid
发明人:JONES JR GERALD S; ST LAURENT JOSEPH P; GOODRICH SCOTT A; MAGUIRE GEORGE
权利人:JONES JR GERALD S; ST LAURENT JOSEPH P; GOODRICH SCOTT A; MAGUIRE GEORGE; CHEMIC LAB INC
摘要:A process for the large-scale chemoenzymatic production of (6S)-5-methyl-5,6,7,8-tetrahydrofolic acid, also known as (6S)-5-methylTHFA, the process comprising the steps of: (1) reducing folic acid (FA) so as to yield dihydrofolic acid (DHFA); (2) stereoselectively reducing DHFA with dihydrofolate reductase (DHFR) in the presence of NADP/NADPH, glucose and GluDH so as to yield (6S)-THFA; (3) converting (6S)-THFA to (6S)-5-methlTHFA; and (4) isolating (6S)-5-methylTHFA.

专利号:US-2009191610-A1
优先权日:2005-08-18
标 题 :Microorganisms With Increased Efficiency for Methionine Synthesis
发明人:ZELDER OSKAR; HEROLD ANDREA; KLOPPROGGE CORINNA; SCHRODER HARTWIG; HAEFNER STEFAN; HEINZLE ELMAR; WITTMANN CHRISTOPH; KROEMER JENS; PERO JANICE G; YOCUM R ROGERS; PATTERSON THOMAS A; WILLIAMS MARK; HERMAN THERON
权利人:EVONIK DEGUSSA GMBH
摘要:The present invention relates to methods for the production of microorganisms with increased efficiency for methionine synthesis, microorganisms with increased efficiency for methionine synthesis, and methods for determining the optimal metabolic flux for organisms with respect to methionine synthesis.

专利号:US-9885064-B2
优先权日:2008-01-22
标 题 :Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol
发明人:BURK MARK J; SCHILLING CHRISTOPHE H; BURGARD ANTHONY P; TRAWICK JOHN D
权利人:GENOMATICA INC
摘要:The invention provides a non-naturally occurring microbial organism having an acetyl-CoA pathway and the capability of utilizing syngas or syngas and methanol. In one embodiment, the invention provides a non-naturally occurring microorganism, comprising one or more exogenous proteins conferring to the microorganism a pathway to convert CO, CO 2 and/or H 2 to acetyl-coenzyme A (acetyl-CoA), methyl tetrahydrofolate (methyl-THF) or other desired products, wherein the microorganism lacks the ability to convert CO or CO 2 and H 2 to acetyl-CoA or methyl-THF in the absence of the one or more exogenous proteins. For example, the microbial organism can contain at least one exogenous nucleic acid encoding an enzyme or protein in an acetyl-CoA pathway. The microbial organism is capable of utilizing synthesis gases comprising CO, CO 2 and/or H 2 , alone or in combination with methanol, to produce acetyl-CoA. The invention additionally provides a method for producing acetyl-CoA, for example, by culturing an acetyl-CoA producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an acetyl-CoA pathway enzyme or protein in a sufficient amount to produce acetyl-CoA, under conditions and for a sufficient period of time to produce acetyl-CoA.

专利号:EP-1645276-A1
优先权日:2004-10-08
标题:Treatment of neurodegenerative disorders
发明人:DURGA JANE; VERHOEF PETRA
权利人:WAGENINGEN CT FOR FOOD SCIENCE
摘要:The present invention is dedicated to the treatment of neurodegenerative disorders, in particular age related cognitive decline and age related hearing loss. These disorders can be alleviated by increasing 10-formyltetrahydrofolate or increasing thymidylate synthesis. The invention is of particular benefit to subjects that are MTHFR 677CT heterozygote and MTHFR 677CC homozygote. n The substance that increases 10-formyltetrahydrofolate or increases thymidylate synthesis is selected from 10-formyltetrahydrofolate, 5-formyltetrahydrofolate, 5,10-methenyltetrahydrofolate, 5,10-methylentetrahydrofolate, methionine, S-adenosylmethionine and poly-glutamate forms of 10-formyltetrahydrofolate, 5-formyltetrahydrofolate, 5,10-methenyltetrahydrofolate and 5,10-methylentetrahydrofolate and the substance may be in an acid or salt or ester form.

专利号:US-2015317458-A1
优先权日:2012-12-06
标 题 :In silico prediction of enhanced nutrient content in plants by metabolic modelling
发明人:LOTZ KATRIN; LEPS MICHAEL; LEMKE RAINER; JUNKER BJOERN; SCHREIBER FALK
权利人:BASF PLANT SCIENCE CO GMBH
摘要:The present invention relates to a method for identifying at least one metabolic conversion step, the modulation of which increases the amount of a metabolite of interest in a plant cell, plant or plant part, said method comprising establishing a stoichiometric network model for the metabolism of the plant cell, plant or plant part including the synthesis pathway for the metabolite of interest, identifying at least one candidate metabolic conversion step by applying at least one algorithm of Growth-coupled Design, and validating the at least one candidate metabolic conversion step by a constraint-based modeling approach in the stoichiometric network model, wherein an increase in the metabolite of interest occurring in said constraint-based modeling approach is indicative for a metabolic conversion step, the modulation of which increases the amount of the metabolite of interest in the plant cell, plant or plant part. The present invention further relates to a method for generating a plant cell, plant or plant part which produces an increased amount of a metabolite of interest when compared to a control, said method comprising identifying a metabolic conversion step, the modulation of which increases a metabolite of interest in a plant cell, plant or plant part, by the method for identifying a metabolic conversion step and modulating the said metabolic conversion step such that the amount of the metabolite of interest is increased in vivo in a plant cell, plant or plant part.

专利号:US-2024318209-A1
优先权日:2023-09-14
标 题 :Genetically engineered bacterium using glucose as substrate for de novo synthesis of vanillin and application thereof
武汉本杰明医药股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.benjaminpharmchem.com
企业联系电话:027-86952072👤
📞武汉本杰明医药股份有限公司 ⚠️参考联系方式
联系人:马小姐
电话:027-86952072
手机:18672771780
传真:027-87569548
邮箱:sales02@benjaminpharmchem.com
通信地址: 武汉市洪山区光谷大道41号
邮编: 430070
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:武汉市洪山区光谷大道41号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
嘉善剑桥生物化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jsjqbio.com
企业联系电话:0573-84899500 13705831171👤
📞嘉善剑桥生物化工有限公司 ⚠️参考联系方式
联系人:钱经理
电话:0573-84899500 13705831171
手机:13705831171
传真:0573-84899600
邮箱:sales@jsjqbio.com
通信地址: 浙江省嘉善县陶庄镇汾湖综合工业园区
邮编: 314105
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江省嘉善县陶庄镇汾湖综合工业园区
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
连云港金康医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jinkang-pharma.com
电话: 0518-85445517 86785201👤
📞连云港金康医药科技有限公司 ⚠️参考联系方式

销售电话:0518-85445517 86785201
邮箱:sales@jinkang-chem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Roselli M, Formica V, Cereda V, Jochems C, Richards J, Grenga I, Orlandi A, Ferroni P, Guadagni F, Schlom J. The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy. Oncoimmunology. 2016 May 19;5(7):e1188243. doi: 10.1080/2162402X.2016.1188243. eCollection 2016 Jul.
2: Wettergren Y, Taflin H, Odin E, Kodeda K, Derwinger K. A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized study. Cancer Chemother Pharmacol. 2015 Jan;75(1):37-47. doi: 10.1007/s00280-014-2611-9. Epub 2014 Oct 24.
3: Gellad WF, Choi P, Mizah M, Good CB, Kesselheim AS. Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011. Am J Manag Care. 2014 Mar 1;20(3):e90-7. doi: 10.1007/s10637-013-0056-3. Epub 2013 Dec 15.

合成参考文献


参考文献:10.1016/j.mito.2011.06.009
摘要:Tondo M, Málaga I, O'Callaghan M, Serrano M, Emperador S, Ormazabal A, Ruiz-Pesini E, Montoya J, Garcia-Silva MT, Martin-Hernandez E, Garcia-Cazorla A, Pineda M, Artuch R. Biochemical parameters to assess choroid plexus dysfunction in Kearns-Sayre syndrome patients. Mitochondrion. 2011 Nov;11(6):867–70. doi: 10.1016/j.mito.2011.06.009.
参考文献:10.3164/jcbn.10-129
摘要:Chung HK, Kim OY, Lee H, Do HJ, Kim YS, Oh J, Kang SM, Shin MJ. Relationship between dietary folate intake and plasma monocyte chemoattractant protein-1 and interleukin-8 in heart failure patients. J Clin Biochem Nutr. 2011 Jul;49(1):62–6.
参考文献:10.1007/s00335-011-9351-5
摘要:Pickell L, Wu Q, Wang XL, Leclerc D, Friedman H, Peterson AC, Rozen R. Targeted insertion of two Mthfr promoters in mice reveals temporal- and tissue-specific regulation. Mamm Genome. 2011 Dec;22(11-12):635–47. doi: 10.1007/s00335-011-9351-5.
参考文献:10.1021/jf201120n
摘要:Wang C, Riedl KM, Somerville J, Balasubramaniam VM, Schwartz SJ. Influence of high-pressure processing on the profile of polyglutamyl 5-methyltetrahydrofolate in selected vegetables. J Agric Food Chem. 2011 Aug 24;59(16):8709–17.
参考文献:10.1016/j.braindev.2011.05.014
摘要:Prasad AN, Rupar CA, Prasad C. Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy. Brain Dev. 2011 Oct;33(9):758–69. doi: 10.1016/j.braindev.2011.05.014.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知